Sarah Nemec's most recent trade in Bolt Biotherapeutics Inc was a trade of 226,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | Sarah Nemec | Senior VP, Finance and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 226,000 | 226,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Sarah Nemec | Senior VP, Finance and PAO | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 01 May 2025 | 2,500 | 13,863 | - | 0.6 | 1,594 | Common Stock |
| Bolt Biotherapeutics Inc | Sarah Nemec | Senior VP, Finance and PAO | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 01 May 2025 | 2,500 | 16,633 | - | 0.5 | 1,241 | Common Stock |
| Bolt Biotherapeutics Inc | Sarah Nemec | VP, Finance and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Sarah Nemec | VP, Finance and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |